What is the dose of Glycopyrrolate for a child weighing 22 kilograms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Glycopyrrolate Dosing for a 22kg Child

For a 22kg child, the recommended dose of glycopyrrolate injection is 0.004 mg/kg, which equals 0.088 mg per dose. This dose can be administered intravenously or intramuscularly based on the clinical indication 1, 2.

Dosing Based on Clinical Indication

Preanesthetic Medication

  • Dose: 0.004 mg/kg IM (0.088 mg for a 22kg child)
  • Timing: 30-60 minutes prior to anesthesia induction or when preanesthetic medications are administered
  • Maximum: Not to exceed 0.1 mg in a single dose 1

Intraoperative Use

  • Dose: 0.004 mg/kg IV (0.088 mg for a 22kg child)
  • Maximum: Not to exceed 0.1 mg in a single dose
  • Frequency: May be repeated at intervals of 2-3 minutes as needed
  • Note: If glycopyrrolate was used as preanesthetic medication, additional intraoperative doses are rarely needed 1, 2

Reversal of Neuromuscular Blockade

  • Dose: 0.2 mg for each 1.0 mg of neostigmine or 5.0 mg of pyridostigmine
  • Administration: Can be mixed in the same syringe with neostigmine or pyridostigmine and administered simultaneously by IV injection 1

Important Considerations

Weight-Based Dosing Precautions

  • For children weighing less than 25kg (like this 22kg child), the standard pediatric dosing of 0.004 mg/kg is appropriate 3
  • The total dose should not exceed 0.1 mg in a single administration 1

Administration Routes

  • Can be administered intramuscularly or intravenously without dilution
  • Compatible with dextrose 5% and 10% in water, saline, dextrose 5% in sodium chloride 0.45%, sodium chloride 0.9%, and Ringer's Injection 1
  • Incompatible with Lactated Ringer's solution 1

Monitoring

  • Monitor for anticholinergic side effects including dry mouth, constipation, urinary retention, flushing, and tachycardia
  • Be particularly vigilant in younger children who may be more sensitive to anticholinergic effects 4

Special Situations

For Chronic Drooling

If glycopyrrolate is being used for chronic drooling in this child:

  • Starting dose: 0.02 mg/kg three times daily (0.44 mg TID for a 22kg child)
  • Titration: Can be increased in increments of 0.02 mg/kg every 5-7 days
  • Maximum dose: 0.1 mg/kg three times daily, not exceeding 3 mg per dose 5
  • Note: While FDA approval for drooling is for children 3-16 years, studies have shown efficacy in younger children as well 6

Overdose Management

If overdose occurs:

  • For peripheral anticholinergic effects: neostigmine methylsulfate may be given IV in proportionately smaller doses than the adult dose of 0.25 mg
  • For CNS symptoms: physostigmine may be used in proportionately smaller doses than the adult dose of 0.5-2 mg 1

Practical Administration Tips

  • Visually inspect solution for particulate matter and discoloration before administration
  • Do not combine glycopyrrolate with medications that would result in a pH higher than 6.0 1
  • Calculate the exact dose carefully based on accurate weight measurement to avoid dosing errors

Remember that glycopyrrolate has a long duration of action, so additional doses for anticholinergic effect are rarely needed if it was used as preanesthetic medication 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.